A real pharmacy name does not authenticate the bottle that arrived
Checking that a pharmacy exists is only one step. If the product’s origin is uncertain, ask that pharmacy to confirm the specific prescription or order attributed to it.
What this comes down to
- Licensure and order origin answer different questions.
- Find pharmacy contact details independently.
- Keep the seller’s order and dispensing records together.
A legitimate name can be copied
FDA describes fraudulent compounded semaglutide and tirzepatide bearing the names of real licensed pharmacies that did not prepare those products. A successful license search therefore cannot authenticate an individual bottle.[1] After authenticating the pharmacy and order, compare the delivered label with the written formulation confirmation; identity and ingredients are separate checks.
FDA’s BeSafeRx resources direct consumers to state pharmacy-board databases for licensing information. Use that record to check the business identity, address and licensing status. Then ask the pharmacy through independently located contact details about the prescription actually received.[2]
Ask about the specific order
Have the patient name, prescription number, dispensing date, product label and seller order reference available. Ask whether the pharmacy dispensed the order and whether the ingredient, strength, quantity and instructions match its record. These are proposed authentication questions; a label photograph alone is not a potency or sterility test.
If the pharmacy cannot locate the order, ask what additional record it needs before drawing a conclusion. A spelling mismatch or missing reference is a reason to investigate, not proof of fraud. Obtain a written response and notify the prescribing platform of the discrepancy.
Keep authentication separate from a replacement claim
Do not assume a platform’s list of pharmacy partners identifies the dispenser of your prescription. A seller can name several pharmacies while assigning one only after clinical review. Keep the final dispensing record rather than relying on a pharmacy-list screenshot.
FDA’s MedWatch program accepts product-quality and product-use-error reports. Reporting a suspected problem is separate from asking the seller or pharmacy to resolve the order. It neither authenticates a product nor determines a refund. Bring unresolved origin concerns to the pharmacist and clinician before using the medicine.[3]
FDA’s reporting instructions distinguish product identifiers from the event description and point consumers to their reporting form. Keep both the suspected product’s identity and the pharmacy’s authentication response; completing a report is not a determination that the order is genuine.[4]
For the related buying question, read checking a compounding pharmacy’s license.
Questions people actually ask
Is an active license enough?
It verifies the licensed business. It does not prove that the business prepared your particular order.
Can a partner list confirm my pharmacy?
No. Ask for the pharmacy named on the actual dispensing record and authenticate that order directly when needed.
Sources
Primary sources and the claims they support.
- 1.FDA unapproved GLP-1 concerns. FDA, 2026. Source · Document dated October 2026Fraudulent products can borrow real pharmacy names.
- 2.
- 3.FDA MedWatch. FDA, 2025. Source · Document dated September 2025Product-quality and product-use-error reporting.
- 4.FDA reporting instructions. FDA, 2026. Source · Document dated May 2026Product identity and event details belong in a report; the consumer-specific reporting form is available.